| Code | 1502D | ||||||||||
| MA number | 73/0087/11-S | ||||||||||
| Product Form: | tbl flm 90x5 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 73 - SPASMOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 10.02.2011 |
| Dokument: |
CMDh_223_2005_Rev1_2012_02 Zevesin.doc
|
| SPC: |
SPC_Zevesin 5 mg_10 mg_tbl flm_03_2020.doc
|
| PIL: |
PIL_Zevesin 5 mg_10 mg_tbl flm_03_2020.doc
|
| Safety feature | Yes |
| Data update: | 20.05.2019 |
